Wells Fargo’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,058
| Closed | -$421K | – | 7361 |
|
|
2024
Q4 | $421K | Buy |
34,058
+9,792
| +40% | +$112K | ﹤0.01% | 4306 |
|
|
2024
Q3 | $276K | Sell |
24,266
-654
| -3% | -$6.56K | ﹤0.01% | 4369 |
|
|
2024
Q2 | $178K | Buy |
24,920
+1,576
| +7% | +$12.1K | ﹤0.01% | 4591 |
|
|
2024
Q1 | $156K | Buy |
23,344
+2,684
| +13% | +$18.5K | ﹤0.01% | 4623 |
|
|
2023
Q4 | $134K | Sell |
20,660
-31,663
| -61% | -$204K | ﹤0.01% | 4722 |
|
|
2023
Q3 | $494K | Sell |
52,323
-16,635
| -24% | -$200K | ﹤0.01% | 3792 |
|
|
2023
Q2 | $963K | Buy |
68,958
+19,208
| +39% | +$327K | ﹤0.01% | 3510 |
|
|
2023
Q1 | $933K | Buy |
49,750
+42,281
| +566% | +$695K | ﹤0.01% | 3422 |
|
|
2022
Q4 | $103K | Sell |
7,469
-3,393
| -31% | -$52K | ﹤0.01% | 4520 |
|
|
2022
Q3 | $208K | Sell |
10,862
-246
| -2% | -$4.48K | ﹤0.01% | 4225 |
|
|
2022
Q2 | $170K | Sell |
11,108
-82,390
| -88% | -$1.22M | ﹤0.01% | 4368 |
|
|
2022
Q1 | $1.9M | Sell |
93,498
-16,395
| -15% | -$334K | ﹤0.01% | 3351 |
|
|
2021
Q4 | $3.21M | Sell |
109,893
-247,832
| -69% | -$7.09M | ﹤0.01% | 3020 |
|
|
2021
Q3 | $7.72M | Buy |
357,725
+177,040
| +98% | +$4.27M | ﹤0.01% | 2447 |
|
|
2021
Q2 | $4.63M | Buy |
180,685
+9,888
| +6% | +$211K | ﹤0.01% | 2939 |
|
|
2021
Q1 | $3.11M | Buy |
170,797
+29,662
| +21% | +$493K | ﹤0.01% | 3298 |
|
|
2020
Q4 | $1.63M | Buy |
141,135
+917
| +0.7% | +$8.38K | ﹤0.01% | 3640 |
|
|
2020
Q3 | $1.07M | Sell |
140,218
-2,727
| -2% | -$20.7K | ﹤0.01% | 3808 |
|
|
2020
Q2 | $937K | Buy |
142,945
+49,590
| +53% | +$277K | ﹤0.01% | 3862 |
|
|
2020
Q1 | $477K | Sell |
93,355
-82,693
| -47% | -$500K | ﹤0.01% | 4066 |
|
|
2019
Q4 | $1.35M | Buy |
176,048
+361
| +0.2% | +$2.11K | ﹤0.01% | 3646 |
|
|
2019
Q3 | $932K | Buy |
175,687
+13,382
| +8% | +$83.1K | ﹤0.01% | 3899 |
|
|
2019
Q2 | $909K | Buy |
162,305
+26,739
| +20% | +$110K | ﹤0.01% | 3933 |
|
|
2019
Q1 | $576K | Buy |
135,566
+38,598
| +40% | +$157K | ﹤0.01% | 4249 |
|
|
2018
Q4 | $398K | Buy |
96,968
+17,558
| +22% | +$91.6K | ﹤0.01% | 4477 |
|
|
2018
Q3 | $545K | Sell |
79,410
-182,758
| -70% | -$1.08M | ﹤0.01% | 4377 |
|
|
2018
Q2 | $1.03M | Buy |
262,168
+42,002
| +19% | +$146K | ﹤0.01% | 3975 |
|
|
2018
Q1 | $644K | Buy |
220,166
+24,262
| +12% | +$75K | ﹤0.01% | 4218 |
|
|
2017
Q4 | $760K | Buy |
195,904
+78,075
| +66% | +$334K | ﹤0.01% | 4102 |
|
|
2017
Q3 | $370K | Buy |
117,829
+69,489
| +144% | +$261K | ﹤0.01% | 4533 |
|
|
2017
Q2 | $206K | Buy |
48,340
+15,679
| +48% | +$64.2K | ﹤0.01% | 4764 |
|
|
2017
Q1 | $149K | Buy |
32,661
+27,178
| +496% | +$91.1K | ﹤0.01% | 4990 |
|
|
2016
Q4 | $12K | Sell |
5,483
-9,714
| -64% | -$22.7K | ﹤0.01% | 5755 |
|
|
2016
Q3 | $46K | Hold |
15,197
| – | – | ﹤0.01% | 5331 |
|
|
2016
Q2 | $39K | Sell |
15,197
-8,376
| -36% | -$23.3K | ﹤0.01% | 5295 |
|
|
2016
Q1 | $70K | Buy |
23,573
+1,228
| +5% | +$6.57K | ﹤0.01% | 5080 |
|
|
2015
Q4 | $182K | Buy |
22,345
+8
| +0% | +$65 | ﹤0.01% | 4520 |
|
|
2015
Q3 | $160K | Buy |
22,337
+99
| +0.4% | +$826 | ﹤0.01% | 4588 |
|
|
2015
Q2 | $204K | Buy |
22,238
+9,731
| +78% | +$93.6K | ﹤0.01% | 4601 |
|
|
2015
Q1 | $118K | Buy |
12,507
+1,031
| +9% | +$9.92K | ﹤0.01% | 4674 |
|
|
2014
Q4 | $111K | Buy |
11,476
+9,895
| +626% | +$99.7K | ﹤0.01% | 4696 |
|
|
2014
Q3 | $15K | Sell |
1,581
-905
| -36% | -$10.1K | ﹤0.01% | 5433 |
|
|
2014
Q2 | $32K | Buy |
2,486
+1,956
| +369% | +$24.7K | ﹤0.01% | 5147 |
|
|
2014
Q1 | $7K | Sell |
530
-29
| -5% | -$382 | ﹤0.01% | 5481 |
|
|
2013
Q4 | $5K | Buy |
559
+81
| +17% | +$762 | ﹤0.01% | 5370 |
|
|
2013
Q3 | $4K | Sell |
478
-28
| -6% | -$278 | ﹤0.01% | 5343 |
|
|
2013
Q2 | $4K | Buy |
+506
| New | +$5.3K | ﹤0.01% | 5265 |
|
Other funds holding CDMO
Wells Fargo's CDMO Position: Q1 2025 in Review
Wells Fargo sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 34,058 shares — an estimated $421K sold.
Wells Fargo first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $7.72M in Q3 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Wells Fargo reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Wells Fargo sold 34,058 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $421K.
- Wells Fargo first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
- Wells Fargo's Avid Bioservices, Inc. Common Stock position peaked at $7.72M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.